Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
Innovative Drug R&D Services

Deeply integrate R&D experience, constantly climb the peak of R&D technology, and build an integrated innovation service platform for new drug R&D

Innovative Drug R&D Services

Medicilon has the global-leading new molecule types R&D platform and extensive experience of cutting-edge projects and closely followed the forefront of new drug R&D technological development.

Medicilon will continue to use the latest technology to enable global pharmaceutical innovation, and continue to invest substantially in further improving service capabilities for new molecule types, such as PROTAC, oligonucleotide, peptide, ADC, bi-specific antibody, cell and gene therapies, to capture new business opportunities and empower global pharmaceutical innovation.

At the same time, Medicilon also has rich experience in molecular design of innovative drugs. Relying on CADD technology, high-throughput screening, bioelectronic isostereometry technology, etc., to establish a more efficient AI-guided drug design and synthesis platform to help customers improve R&D efficiency, and reduce R&D barriers.

Return